2018 News

Keyword Search
2018 | 2017 | 2016 | 2015 | 2014
Jan 18, 2018CTI BioPharma to Receive $10 Million Milestone Payment for TRISENOX®
SEATTLE, Jan. 18, 2018 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ and MTA:CTIC) today announced that it expects to receive a $10 million milestone payment in February, 2018 from Teva Pharmaceutical Industries Ltd.  related to the achievement of a milestone for U.S. Food and Drug Administration approval of TRISENOX® (arsenic trioxide) for first line treatment of acute promyelocytic leukemia. The milestone will be paid pursuant to an acquisition agreement for TRISENOX previously entered into with... 
Printer Friendly Version